Polocaine With Levonordefrin
NDC Package 66312-460-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Polocaine With Levonordefrin is a . Marketed by Dentsply Pharmaceutical, this product is identified by NDC 66312-460 and is authorized under FDA application ANDA089517.

Identification & Billing

NDC Package Code
66312-460-14
Package Description
100 CARTRIDGE in 1 CARTON / 1.8 mL in 1 CARTRIDGE
Product Code
66312-460
11-Digit Billing Format
66312046014

Clinical Specifications

Proprietary Name
Polocaine With Levonordefrin
Dosage Form
-

Regulatory & Marketing

Labeler Name
Dentsply Pharmaceutical
FDA Application #
ANDA089517
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-08-2001
End Marketing Date
01-20-2009
Listing Expiration
01-20-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66312-460-14 identifies a specific commercial package of 100 cartridge in 1 carton / 1.8 ml in 1 cartridge of Polocaine With Levonordefrin, labeled by Dentsply Pharmaceutical. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dentsply Pharmaceutical on May 08, 2001. The current certification is valid through January 20, 2009.

How is this Dentsply Pharmaceutical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66312046014. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66312-460-14
11-Digit CMS (5-4-2)
66312-0460-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.